Growth • InMode
INMD
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
20,4%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
13,5%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
24,3%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
23%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
16,4%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!